Fotini Gounari

Appointments:

Assistant Professor
Department of Medicine

Committee on Immunology

Education:

Ph.D.     National Institute for Medical
               Research, London, UK  1986

H.D.R. (D.Sc.)  Rene Descartes
               University,  Paris, France  1998

Contact:

Phone:  (773) 702-3912

Fax:       (773) 834-8150

E-Mail: 
fgounari@uchicago.edu

Address:

The University of Chicago
AMB N005,  MC 0930
5841 South Maryland Avenue
Chicago, Illinois 60637

Related Research Interests:

 Apoptosis

Cancer Genetics

Cell Differentiation/ Development

Gene Regulation/ Expression

Hematopoiesis

Immune Regulation and Manipulation

Leukemia

Molecular Immunology

Signal Transduction

T/B Cell Development

Fotini Gounari, Ph.D.


Thymocyte Development and Transformation

Research Summary

Unlike other hematopoietic lineages that complete their developmental process in the bone marrow, T-cell development requires an obligatory travel of progenitors to the thymus where commitment and maturation to the T-cell lineage takes place.  Our lab focuses on signaling pathways whose function and disfunction can explain the physiology and pathology of T cell development.  The assembly and function of the pre-T cell receptor (pre-TCR), marks commitment to the alphabeta-T cell lineage, through molecular events that are poorly understood.  We have shown that activation of the wnt/beta-catenin pathway promotes T cell maturation in the absence of the pre-TCR, and therefore may act downstream the pre-TCR signaling, it also stalls thymocyte development at the DP stage acting downstream alphabeta-TCR signaling.  Uncontrolled beta-catenin activity predisposes thymocytes to transformation leading to thymic Lymphomas.  Activation of wnt/beta-catenin signaling has been proposed to drive self-renewal of hematopoietic stem cells, the source of all cell lineages in the blood, and is known to be the initiating event in colon cancer, promoting expansion of aberrant stem cells.  T cell development is also critically dependent on Notch signaling, while its deregulated activation has been associated with human T-cell leukemias, and with acute leukemia in mice.  These leukemias require preTCR signaling.  All together, these observations suggest that the pre-TCR lies at the crossroad to at least two major signaling pathways, whose cross talk is central both for development and malignant transformation of T cells:  wnt/beta-catenin and Notch.

Research in my lab aims at clarifying the cross talk between the signals emanating from the pre-TCR, wnt/beta-catenin, and Notch pathways, using transgenic animals as well as in vitro techniques.  Animal models engineered to express the pre-TCR in an inducible manner are used to examine whether the pre-TCR directly modulates the other two pathways, or is acting in parallel.  We examine whether leukemias caused by wnt/beta-catenin like those induced by Notch, require or benefit from the action of pre-TCR or the alphabeta TCR.  Finally, we are examining the interdependence of these three pathways in promoting T cell development and inducing leukemia. Defining the precise role of wnt/beta-catenin and Notch and their interconnection with pre-TCR signaling in T cell development will open new horizons in our understanding of the controlled transition of hematopoietic stem cells into the mature alphabeta T cell lineage. Defining the role of pre-TCR signaling and its cross talk with other two pathways in leukemia, will highlight potential targets for therapeutic intervention in the cascade of events that promote and maintain T cell leukemias.


Selected Papers

Martin C.H., Aifantis I., Scimone M.L., von Andrian U.H., Reizis B., von Boehmer H., and Gounari F. Efficient thymic immigration of B220+ lymphoid-restricted bone marrow cells with T precursor potential. Nat Immunol. 4: 866-873, (2003).

Borowski C., Li X., Aifantis I., Gounari F., and von Boehmer H. PreTCR a and TCR a are not interchangeable partners of TCRb during T lymphocyte development. Journal of Experimental Medicine 199: 607-15. (2004).


Karagianni N, Ly MC, Psarras S, Chlichlia K, Schirrmacher V, Gounari F, Khazaie K. Novel adenomatous polyposis coli gene promoter is located 40 kb upstream of the initiating methionine. Genomics. 85: 231-237 (2005).

Gounari F.*, Chang R., Cowan J., Guo Z., Dose M., Gounaris E. & Khazaie K. Loss of the Adenomatous-Polyposis-Coli gene function disrupts thymic development. Nat. Immunol. 6: 800-809. (2005).

Garbe A. I., Krueger A., Gounari F., Zuniga-Pflucker J-C. and von Boehmer H. Differential synergy of Notch and T cell receptor signaling determines versus  lineage fate. Journal of Experimental Medicine 203: 1579-90. (2006).

Dose M., Khan I., Guo Z., Kovalovsky D., Krueger A., von Boehmer H., Khazaie K., and Gounari F.* c-Myc mediates preTCR induced proliferation but not developmental progression. Blood 108: 2669- 2677. (2006).

Guo Z, Dose M, Kovalovsky D, Chang R, O'Neil J, Look AT, von Boehmer H, Khazaie K, Gounari F. *    Beta-catenin stabilization stalls the transition from double-positive to single-positive stage and predisposes thymocytes to malignant transformation. Blood. 109: 5463-72. (2007).

Mao C, Tili EG, Dose M, Haks MC, Bear SE, Maroulakou I, Horie K, Gaitanaris GA, Fidanza V, Ludwig T, Wiest DL, Gounari F, Tsichlis PN. Unequal contribution of Akt isoforms in the double-negative to double-positive thymocyte transition. J Immunol. 178: 5443-53. (2007).

Gounaris E, Erdman SE, Restaino C, Gurish MF, Friend DS, Gounari F, Lee DM, Zhang G, Glickman JN, Shin K, Rao VP, Poutahidis T, Weissleder R, McNagny KM, Khazaie K. Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci Usa 104: 19977-82. (2007).

Gounari, F. and Dose, M. Lef-1: NOTCHed up in T-cell lymphomas Blood 110:2227. (2007).


 

Faculty and Research

Programs

Cancer Biology


CCB

Immunology


COI

Microbiology


COM

Molecular Metabolism
and Nutrition


CMMN

Molecular Pathogenesis and
Molecular Medicine


MPMM